Vinca alkaloid antimitotic agents delivered via intravenous injection for leukemia, lymphoma, and solid tumors. Administered in hematology-oncology units by specialized nurses under physician supervision. Manufactured by biotech firms, distributed to infusion centers and cancer hospitals through specialized logistics.